[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Arteris, Inc. reported a Form 144 notice for the proposed sale of 5,755 common shares with an aggregate market value of $63,189.90, showing an approximate sale date of 10/06/2025 on NASDAQ. The securities were originally acquired on 06/16/2014 in a private acquisition from the issuer and paid for in cash. The filing lists multiple recent dispositions by the related party, including several 10b5-1 sales and direct sales by K. CHARLES JANAC totalling sizeable proceeds in August–October 2025 (examples: $1,271,120.01 for 94,245 shares on 08/05/2025; $655,995.00 for 50,000 shares on 08/05/2025). The filing includes the required representation that the seller is not aware of undisclosed material adverse information.

Positive

• Planned 10b5-1 trades are listed for several transactions, indicating use of pre-arranged trading plans
• Broker involvement noted (Morgan Stanley Smith Barney LLC), suggesting professional execution and recordkeeping

Negative

• Recent large insider sales include 94,245 shares for $1,271,120.01 and 50,000 shares for $655,995.00 on 08/05/2025, increasing available insider supply
• Form 144 lacks a stated 10b5-1 plan adoption date within the remarks, leaving timing of pre‑arranged instructions unclear in this filing

Insights

Insider Trading Analyst

Small scheduled Rule 144 sale follows several recent 10b5-1 and ad hoc dispositions.

The notice covers 5,755 shares valued at $63,189.90 with an approximate sale date of 10/06/2025, while the schedule of recent sales shows multiple larger transactions, including 94,245 shares for $1,271,120.01 and 50,000 shares for $655,995.00 on 08/05/2025. These entries include both labeled 10b5-1 plan sales and direct sales by K. CHARLES JANAC, indicating a mix of pre-arranged and discretionary dispositions.

The pattern suggests staged liquidity events rather than a single large block sale; monitor whether further 10b5-1 notices or additional Form 144 filings appear in the next 30–90 days to assess ongoing insider supply pressure.

Securities Compliance Expert

The filing documents compliance with Rule 144 mechanics and includes a standard representation about material non‑public information.

The securities to be sold were acquired from the issuer on 06/16/2014 and paid in cash, and the notice names the executing broker as Morgan Stanley Smith Barney LLC. Several prior sales in the past three months are itemized with dates and gross proceeds, and some are explicitly identified as 10b5-1 plan trades, which provides an affirmative defense if properly adopted and executed.

Absent a disclosed plan adoption date in this form, stakeholders may look for accompanying 10b5-1 plan documentation or check periodic filings for the plan adoption date to confirm the timing and compliance of pre-arranged trades within the next regulatory reporting cycle.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5755	63189.90	42649917	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/16/2014	Private Acquisition from Issuer or an Affiliate	Issuer			5755	06/16/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/03/2025	11821	130864.34
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	7147	78050.96
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/04/2025	2057	17948.35
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	1246	1552516.00
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	94245	1271120.01
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	50000	655995.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arteris (AIP) Form 144 report?

The filing notifies a proposed sale of 5,755 common shares valued at $63,189.90 with an approximate sale date of 10/06/2025.

Who is selling the shares in the AIP Form 144?

The filing references sales associated with K. CHARLES JANAC and related 10b5-1 sales; some transactions are labeled as executed for named parties.

Were the shares being sold originally acquired from the issuer?

Yes; the securities to be sold were acquired on 06/16/2014 in a private acquisition from the issuer and paid in cash.

Have there been recent related-party sales for AIP?

Yes; the filing lists multiple sales in the past three months, including 94,245 shares for $1,271,120.01 and 50,000 shares for $655,995.00 on 08/05/2025.

Which broker is named for the proposed sale?

The executing broker is Morgan Stanley Smith Barney LLC (address: Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004).